Van Damme P - Search Results

1

Model based estimates of long-term persistence of inactivated hepatitis A vaccine-induced antibodies in adults.

Hens N, Habteab Ghebretinsae A, Hardt K, Van Damme P, Van Herck K. Hens N, et al. Among authors: van damme p, van herck k. Vaccine. 2014 Mar 14;32(13):1507-13. doi: 10.1016/j.vaccine.2013.10.088. Epub 2014 Feb 7. Vaccine. 2014. PMID: 24508042 Clinical Trial.

2

Hepatitis B vaccination: how to reach risk groups.

François G, Hallauer J, Van Damme P. François G, et al. Among authors: van damme p. Vaccine. 2002 Nov 22;21(1-2):1-4. doi: 10.1016/s0264-410x(02)00440-1. Vaccine. 2002. PMID: 12443655

3

Travelers' knowledge, attitudes, and practices on prevention of infectious diseases: results from a pilot study.

Van Herck K, Zuckerman J, Castelli F, Van Damme P, Walker E, Steffen R; European Travel Health Advisory Board. Van Herck K, et al. Among authors: van damme p. J Travel Med. 2003 Mar-Apr;10(2):75-8. doi: 10.2310/7060.2003.31638. J Travel Med. 2003. PMID: 12650648 Free article.

4

Rapid protection and vaccination against hepatitis A for travellers.

Connor BA, Van Herck K, Van Damme P. Connor BA, et al. Among authors: van damme p, van herck k. BioDrugs. 2003;17 Suppl 1:19-21. doi: 10.2165/00063030-200317001-00005. BioDrugs. 2003. PMID: 12785874 Review. No abstract available.

5

Long-term protection after hepatitis A and B vaccination: an update.

Van Damme P. Van Damme P. Acta Gastroenterol Belg. 2003 Jul-Sep;66(3):247-9. Acta Gastroenterol Belg. 2003. PMID: 14618958 No abstract available.

6

An economic evaluation of varicella vaccination in Italian adolescents.

Thiry N, Beutels P, Tancredi F, Romanò L, Zanetti A, Bonanni P, Gabutti G, Van Damme P. Thiry N, et al. Among authors: van damme p. Vaccine. 2004 Sep 9;22(27-28):3546-62. doi: 10.1016/j.vaccine.2004.03.043. Vaccine. 2004. PMID: 15315834

7

The global impact of vaccination against hepatitis B: a historical overview.

Zanetti AR, Van Damme P, Shouval D. Zanetti AR, et al. Among authors: van damme p. Vaccine. 2008 Nov 18;26(49):6266-73. doi: 10.1016/j.vaccine.2008.09.056. Epub 2008 Oct 9. Vaccine. 2008. PMID: 18848855 Review.

8

Five years follow-up following two or three doses of a hepatitis B vaccine in adolescents aged 11-15 years: a randomised controlled study.

Van Damme P, Moiseeva A, Marichev I, Kervyn AD, Booy R, Kuriyakose S, Brockway A, Ng SP, Leyssen M, Jacquet JM. Van Damme P, et al. BMC Infect Dis. 2010 Dec 20;10:357. doi: 10.1186/1471-2334-10-357. BMC Infect Dis. 2010. PMID: 21171982 Free PMC article. Clinical Trial.

9

Long-term immunogenicity and immune memory after two doses of the adult formulation of a combined hepatitis A and B vaccine in children 1 to 11 years of age.

van Damme P, Kafeja F, Van Der Wielen M, Leyssen M, Jacquet JM. van Damme P, et al. Among authors: van der wielen m. Pediatr Infect Dis J. 2011 Aug;30(8):703-5. doi: 10.1097/INF.0b013e3182138296. Pediatr Infect Dis J. 2011. PMID: 21346683

10

Hepatitis B and the need for a booster dose.

Leuridan E, Van Damme P. Leuridan E, et al. Among authors: van damme p. Clin Infect Dis. 2011 Jul 1;53(1):68-75. doi: 10.1093/cid/cir270. Clin Infect Dis. 2011. PMID: 21653306

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,264 results

Search Page

Filters